16053662

Source:http://linkedlifedata.com/resource/pubmed/id/16053662

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007131, umls-concept:C0013216, umls-concept:C0205195, umls-concept:C0205390, umls-concept:C0599894, umls-concept:C1257954, umls-concept:C1565860, umls-concept:C1705323
pubmed:issue	3
pubmed:dateCreated	2005-8-1
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16053662-16053664
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100931981
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone
pubmed:status	MEDLINE
pubmed:issn	1528-9117
pubmed:author	pubmed-author:AisnerJosephJ
pubmed:issnType	Print
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	201-3
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:16053662-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16053662-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:16053662-Clinical Trials, Phase III as Topic, pubmed-meshheading:16053662-Cyclooxygenase Inhibitors, pubmed-meshheading:16053662-Dinoprostone, pubmed-meshheading:16053662-Humans, pubmed-meshheading:16053662-Lung Neoplasms
pubmed:articleTitle	Targeting COX-2/PG-E2 with a COX-2 inhibitor in combination with chemotherapy for non-small cell lung cancer: are we ready for phase III?
pubmed:affiliation	Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, and the Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, USA. aisnerjo@umdnj.edu
pubmed:publicationType	Journal Article, Comment